| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-A71883111 |
| PharmacoGx | BRD-A71883111 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRC14 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | KAT7 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | UBE2G2 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | GPR173 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.03 |
| mRNA | CALU | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | FUT4 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | COIL | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | EEF1E1-BLOC1S5 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | SNX14 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | UNC13B | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
